Cambrex Acquires Majority Stake in Indian Firm

Cambrex (East Rutherford, NJ) says it has acquired a 51% stake in Zenara Pharma (Hyderabad, India), a pharmaceutical company focused on the formulation of final dosage form products, for $20 million. The company will be renamed Cambrex Zenara. Cambrex will acquire the remaining 49% stake in Zenara in early 2016, pursuant to the stock purchase agreement. The acquisition positions Cambrex as one of the leading global suppliers to the large and growing nicotine replacement therapy (NRT) market providing both active pharmaceutical ingredients (APIs) and finished...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers